Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Times Interest Earned (2018 - 2025)

10x Genomics' Times Interest Earned history spans 8 years, with the latest figure at $10747.3 for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 151.81% to $10747.3 in Q3 2025 year-over-year; TTM through Jun 2025 was -$20105.2, a 12.66% increase, with the full-year FY2024 number at -$48639.8, down 504.95% from a year prior.
  • Times Interest Earned hit $10747.3 in Q3 2025 for 10x Genomics, up from $10042.0 in the prior quarter.
  • Over the last five years, Times Interest Earned for TXG hit a ceiling of $10747.3 in Q3 2025 and a floor of -$94795.0 in Q3 2023.
  • Historically, Times Interest Earned has averaged -$13057.1 across 5 years, with a median of -$350.84 in 2022.
  • Biggest five-year swings in Times Interest Earned: tumbled 26919.28% in 2023 and later soared 151.81% in 2025.
  • Tracing TXG's Times Interest Earned over 5 years: stood at -$72.95 in 2021, then plummeted by 153.28% to -$184.77 in 2022, then crashed by 3633.6% to -$6898.5 in 2023, then plummeted by 200.68% to -$20742.5 in 2024, then soared by 151.81% to $10747.3 in 2025.
  • Business Quant data shows Times Interest Earned for TXG at $10747.3 in Q3 2025, $10042.0 in Q2 2025, and -$20742.5 in Q3 2024.